Tekla Life Sciences Investors (HQL) — Net Asset Quality Index
Tekla Life Sciences Investors (HQL) has a Net Asset Quality Index of 99.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $515.38 Million minus total liabilities of $1.73 Million yields net assets of $513.66 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check how resilient are Tekla Life Sciences Investors's assets to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Tekla Life Sciences Investors Net Asset Quality Index Over Time (1996–2025)
This chart shows how Tekla Life Sciences Investors's Net Asset Quality Index has evolved across 28 annual periods from 1996 to 2025. As of September 2025, the index stands at 99.7%, representing net assets of $513.66 Million against total assets of $515.38 Million USD. See how liquid is Tekla Life Sciences Investors's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Tekla Life Sciences Investors (1996–2025)
The table below presents the year-by-year Net Asset Quality Index for Tekla Life Sciences Investors from 1996 to 2025, covering 28 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see HQL market cap overview.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.7% | $513.66 Million | $515.38 Million | $1.73 Million | ▼ -0.1 pp |
| 2024 | 99.8% | $459.69 Million | $460.58 Million | $888.61K | ▼ 0.0 pp |
| 2023 | 99.8% | $401.93 Million | $402.60 Million | $666.96K | ▲ +3.9 pp |
| 2022 | 95.9% | $397.90 Million | $414.73 Million | $16.82 Million | ▼ -2.0 pp |
| 2021 | 98.0% | $523.44 Million | $534.19 Million | $10.75 Million | ▼ -1.9 pp |
| 2020 | 99.9% | $483.57 Million | $484.17 Million | $595.18K | ▲ +0.6 pp |
| 2019 | 99.3% | $384.16 Million | $386.98 Million | $2.82 Million | ▼ -0.1 pp |
| 2018 | 99.4% | $475.49 Million | $478.47 Million | $2.98 Million | ▼ -0.2 pp |
| 2017 | 99.6% | $466.35 Million | $468.33 Million | $1.98 Million | ▲ +0.2 pp |
| 2016 | 99.4% | $414.97 Million | $417.63 Million | $2.66 Million | ▲ +0.4 pp |
| 2015 | 98.9% | $462.84 Million | $467.85 Million | $5.01 Million | ▼ -0.9 pp |
| 2014 | 99.8% | $444.09 Million | $444.84 Million | $754.55K | ▲ +0.0 pp |
| 2013 | 99.8% | $302.29 Million | $302.82 Million | $530.12K | ▲ +0.0 pp |
| 2012 | 99.8% | $227.08 Million | $227.48 Million | $404.67K | ▲ +0.4 pp |
| 2011 | 99.4% | $170.60 Million | $171.60 Million | $1.00 Million | ▲ +1.5 pp |
| 2010 | 97.9% | $251.40 Million | $256.80 Million | $5.40 Million | ▲ +4.1 pp |
| 2009 | 93.8% | $248.60 Million | $265.10 Million | $16.50 Million | ▼ -5.1 pp |
| 2008 | 98.9% | $277.80 Million | $281.00 Million | $3.20 Million | ▼ -0.8 pp |
| 2007 | 99.6% | $308.00 Million | $309.10 Million | $1.10 Million | ▲ +0.6 pp |
| 2006 | 99.0% | $268.10 Million | $270.80 Million | $2.70 Million | ▼ -0.6 pp |
| 2005 | 99.6% | $229.30 Million | $230.30 Million | $1.00 Million | ▲ +0.2 pp |
| 2004 | 99.3% | $191.80 Million | $193.10 Million | $1.30 Million | ▲ +0.7 pp |
| 2003 | 98.7% | $190.40 Million | $193.00 Million | $2.60 Million | ▼ -1.2 pp |
| 2002 | 99.8% | $157.60 Million | $157.90 Million | $300.00K | ▲ +0.2 pp |
| 2001 | 99.6% | $215.10 Million | $215.90 Million | $800.00K | ▲ +1.0 pp |
| 1998 | 98.6% | $100.00 Million | $101.40 Million | $1.40 Million | ▼ -1.2 pp |
| 1997 | 99.8% | $132.00 Million | $132.20 Million | $200.00K | ▲ +0.3 pp |
| 1996 | 99.5% | $123.10 Million | $123.70 Million | $600.00K | — |